HP184 (Nerispirdine)

I removed HP184 (aka nerispirdine) (Sanofi-Aventis) from the phase 2 list based on this corporate document (page 51) from 2011, which says that the phase 2 trial of nerispirdine for MS was abandoned.

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: